Caspase-3 is dually regulated by apoptogenic factors. mitochondrial release and by SAPK/JNK metabolic pathway in leukemic cells exposed to etoposide-ionizing radiation combined treatment

被引:22
作者
Di Pietro, R [1 ]
Centurione, L
Sabatini, N
Bosco, D
Sancilio, S
Garaci, F
Rana, R
Cataldi, A
机构
[1] Univ G dAnnunzio, Dipartimento Biomorfol, I-66100 Chieti, Italy
[2] Univ G dAnnunzio, Fac Farm, Cattedra Anat Umana, I-66100 Chieti, Italy
[3] CNR, Ist Trapianti Organ & Immunocitol, Chieti, Italy
[4] Univ Roma Tor Vergata, Policlin Tor Vergata, Dipartimento Diagnost Immagini & Radiol Intervent, Rome, Italy
关键词
caspase-3; apoptosome; SAPK/JNK pathway; leukemic cells; etoposide; ionizing radiation;
D O I
10.1177/039463200401700210
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Ionizing radiation induces a series of multiple intracellular events which can lead to activation of caspases, cytoplasmic proteases involved in the occurrence of apoptosis. The response of leukemic cells to ionizing radiation is amplified when they have been pre-treated with the anticancer drug etoposide, therefore the aim of this work has been to establish the lowest etoposide concentration combined with the lowest ionizing radiation dose to obtain the best antineoplastic response. Two leukemic cell lines, HL-60 and Jurkat, employed in this study, demonstrated different sensitivities to ionizing radiation and to etoposide treatment, with Jurkat T cells requiring a higher dose (1 muM) to display cell cycle perturbation and apoptotic DNA damage similar to those seen in HL-60. We hypothesize that this kind of response could be mediated by mitochondrial release of apoptogenic factors and by SAPK/JNK metabolic pathway activation, both leading to caspase-3 cleavage. All in all these results provide insight into the sensitivity or resistance of leukemic cells to antineoplastic agents and identify molecular targets for rational therapeutic intervention strategies.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 38 条
[2]
Oxidative stress and apoptosis in immune diseases [J].
Agostini, M ;
Di Marco, B ;
Nocentini, G ;
Delfino, DV .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2002, 15 (03) :157-164
[3]
ALRIDGE DR, 1998, CANCER RES, V58, P2817
[4]
[Anonymous], [No title captured]
[5]
Apoptosome-independent pathway for apoptosis -: Biochemical analysis of APAF-1 defects and biological outcomes [J].
Belmokhtar, CA ;
Hillion, J ;
Dudognon, C ;
Fiorentino, S ;
Flexor, M ;
Lanotte, M ;
Ségal-Bendirdjian, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) :29571-29580
[6]
Role of nuclear PKC δ in mediating caspase-3-upregulation in Jurkat T leukemic cells exposed to ionizing radiation [J].
Cataldi, A ;
Miscia, S ;
Centurione, L ;
Rapino, M ;
Bosco, D ;
Grifone, G ;
Di Valerio, V ;
Garaci, F ;
Rana, R .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 86 (03) :553-560
[7]
Caspases: the executioners of apoptosis [J].
Cohen, GM .
BIOCHEMICAL JOURNAL, 1997, 326 :1-16
[8]
Dahlberg WK, 1999, CANCER RES, V59, P5365
[9]
FALCIERI E, 1994, HISTOCHEMISTRY, V102, P221
[10]
Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells) [J].
Fujino, M ;
Li, XK ;
Kitazawa, Y ;
Guo, L ;
Kawasaki, M ;
Funeshima, I ;
Amano, T ;
Suzuki, S .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) :939-945